Nidto-Cid, M., Gsrriga-Baraut, T., Plaza-Martin, A., Tortajada-Girbes, M., Torres-Borrego, J., Lozano-Blasco, J., . . . Nieto-Garcia, A. (2023). Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain.
Citación estilo ChicagoNidto-Cid, M., et al. Cost-effectiveness of Omalizumab for the Treatment of Severe Pediatric Allergic Asthma-Results of a Real-life Study in Spain. 2023.
Cita MLANidto-Cid, M., et al. Cost-effectiveness of Omalizumab for the Treatment of Severe Pediatric Allergic Asthma-Results of a Real-life Study in Spain. 2023.
Precaución: Estas citas no son 100% exactas.